An observational study in HIV Testing, HEPATITIS C (HCV) and Syphilis, sponsored by West Virginia University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-13.
Sponsored by West Virginia University · Observational
West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges. Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results. This study, conducted by the West Virginia University (WVU) Street Medicine program, evaluates a rapid, point-of-care fingerstick test for HIV, Hepatitis C, and syphilis that provides results within 10-20 minutes during mobile clinic visits. Participants may choose rapid testing, traditional blood draw (which also includes Hepatitis B screening), or decline testing. All participants will be invited to complete a brief survey about the experiences with screening methods. The goal is to assess whether rapid testing improves screening uptake, linkage to care, and patient satisfaction, ultimately reducing barriers and disease burden in high-risk populations.
1,743 studies on the registry are indexed under Hepatitis C; 97 are open to participants now.
This study's planned enrollment of 200 is close to the median of 218 across 435 observational studies indexed under Hepatitis C.
Browse Hepatitis C studies →West Virginia University is the lead sponsor of 157 studies on the registry; 36 are open to participants now.
Of its 19 completed or terminated interventional studies of FDA-regulated products, 16 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Participants will include patients in Berkeley and Jefferson Counties of West Virginia who visit the WVU Medicine Street Medicine Clinic.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
* Will get a quick fingerstick test for HIV, Hepatitis C, and syphilis. * Will receive results in 10-20 minutes. * If positive, will be offered immediate care and/or a referral. * If positive, blood draw will be offered on site to confirm results or referred to a WVU Medicine clinic location for follow-up blood test. * Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes).
Diagnostic Test: Rapid Fingerstick Test
Participants receiving blood-draw test: * Will get a blood draw to test for HIV, Hepatitis B \& C, and syphilis * Will receive results in approximately 3 days (via MyChart message and phone call, or in person at site) * If positive, will be offered immediate care and/or a referral for follow-up care. • Will be invited to answer questions about the feelings and experiences with screening (about 15 minutes).
Diagnostic Test: Blood Draw for lab test
Participants who decline screening: • Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes).
Fingerstick test for HIV, Hepatitis B and C, and Syphilis that gives results within 10-20 minutes
Blood draw to test for HIV, Hepatitis B \& C, and syphilis which can take up to 3 days for results
Percentage of Finger Stick
Percentage of participants that opted to take the rapid finger stick test.
Time frame: Day 1
Percentage of Blood Draw
Percentage of participants that opted to take the blood draw test.
Time frame: Day 1
Percentage that decline screening
Percentage of participants that opted to decline screening
Time frame: Day 1
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.